ESC Professional Premium Access

Anticoagulant therapy: real world use and clinical challenges

Event: ESC Congress 2022
Topic: Treatment
Session type: Moderated ePosters
Date: 28 August 2022
Time: 10:15 - 10:55

Congress Session

5 presentations in this session

Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: a nationwide cohort study

Speaker: Mr M. Grymonprez (Ghent, BE)
Thumbnail

Oral anticoagulation in patients with atrial fibrillation and stage IV and V chronic kidney disease: a systematic review and meta-analysis

Speaker: Doctor A. Miranda-Arboleda (Medellin, CO)
Thumbnail

The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure

Speaker: Professor J. Siller-Matula (Vienna, AT)
Thumbnail

Potentially inappropriate prescribing and its demographic and clinical correlates in older adults with atrial fibrillation: a population-based study

Speaker: Ms C. Amrouch (Ghent, BE)
Thumbnail

The effect of eplerenone on the disease onset and progression of phospholamban cardiomyopathy in presymptomatic mutation carriers: results of the i-PHORECAST trial

Speaker: Mr R. De Brouwer (Groningen, NL)
Thumbnail

5 speakers from this session

Mr Maxim Grymonprez

Ghent University, Ghent (Belgium)
0 follower

Doctor Andres F Miranda-Arboleda

Clinica Cardiovid, Medellin (Colombia)
1 presentation
0 follower

Professor Jolanta Siller-Matula

Medical University of Vienna, Vienna (Austria)
1 presentation
0 follower

Ms Cheima Amrouch

Ghent University, Ghent (Belgium)
0 follower

Mr Remco De Brouwer

University Medical Centre Groningen, Groningen (Netherlands (The))
0 follower

This platform is supported by

logo Novo Nordisk